Validation of the Royal Marsden Hospital Prognostic Index in Advanced Esophagogastric Cancer Using Individual Patient Data From the REAL 2 Study

被引：36

作者：

Chau, Ian ^{[1
,2
]}

Ashley, Sue ^{[3
]}

Cunningham, David ^{[1
,2
]}

机构：

[1] Royal Marsden Hosp, Dept Med, London SW3 6JJ, England

[2] Royal Marsden Hosp, Dept Med, Surrey, England

[3] Royal Marsden Hosp, Dept Clin Res & Dev, Surrey, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 19期

关键词：

ADVANCED GASTRIC-CANCER; PHASE-III; CISPLATIN; ADENOCARCINOMA; CHEMOTHERAPY; SURVIVAL; FLUOROURACIL; OXALIPLATIN; LYMPHOMA; MODEL;

D O I：

10.1200/JCO.2009.22.0863

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E3 / E4

页数：2

共 10 条

[1] Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin:: A study of the arbeitsgemeinschaft internistische onkologie [J].

Al-Batran, Salah-Eddin ;

Hartmann, Joerg Thomas ;

Probst, Stephan ;

Schmalenberg, Harald ;

Hollerbach, Stephan ;

Hofheinz, Ralf ;

Rethwisch, Volker ;

Seipelt, Gernot ;

Homann, Nils ;

Wilhelm, Gerhard ;

Schuch, Gunter ;

Stoehlmacher, Jan ;

Derigs, Hans Guenter ;

Hegewisch-Becker, Susanna ;

Grossmann, Johannes ;

Pauligk, Claudia ;

Atmaca, Akin ;

Bokemeyer, Carsten ;

Knuth, Alexander ;

Jaeger, Elke .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) :1435-1442

[2] Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data [J].

Chou, I ;

Norman, AR ;

Cunningham, D ;

Waters, JS ;

Oates, J ;

Ross, PJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2395-2403

[3] Capecitabine and oxaliplatin for advanced esophagogastric cancer [J].

Cunningham, David ;

Starling, Naureen ;

Rao, Sheela ;

Iveson, Timothy ;

Nicolson, Marianne ;

Coxon, Fareeda ;

Middleton, Gary ;

Daniel, Francis ;

Oates, Jacqueline ;

Norman, Andrew Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :36-46

[4] Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction [J].

Dank, M. ;

Zaluski, J. ;

Barone, C. ;

Valvere, V. ;

Yalcin, S. ;

Peschel, C. ;

Wenczl, M. ;

Goker, E. ;

Cisar, L. ;

Wang, K. ;

Bugat, R. .

ANNALS OF ONCOLOGY, 2008, 19 (08) :1450-1457

[5] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy [J].

Kim, Jong Gwang ;

Ryoo, Baek-Yeol ;

Park, Yeon Hee ;

Kim, Bong-Seog ;

Kim, Tae-You ;

Im, Young-Hyuck ;

Kang, Yoon-Koo .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (02) :301-307

[6] Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma [J].

Lee, J. ;

Lim, T. ;

Uhm, J. E. ;

Park, K. W. ;

Park, S. H. ;

Lee, S. C. ;

Park, J. O. ;

Park, Y. S. ;

Lim, H. Y. ;

Sohn, T. S. ;

Noh, J. H. ;

Heo, J. S. ;

Park, C. K. ;

Kim, S. ;

Kang, W. K. .

ANNALS OF ONCOLOGY, 2007, 18 (05) :886-891

[7] Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma [J].

Motzer, RJ ;

Bacik, J ;

Schwartz, LH ;

Reuter, V ;

Russo, P ;

Marion, S ;

Mazumdar, M .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :454-463

[8] A PREDICTIVE MODEL FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA [J].

SHIPP, MA ;

HARRINGTON, DP ;

ANDERSON, JR ;

ARMITAGE, JO ;

BONADONNA, G ;

BRITTINGER, G ;

CABANILLAS, F ;

CANELLOS, GP ;

COIFFIER, B ;

CONNORS, JM ;

COWAN, RA ;

CROWTHER, D ;

DAHLBERG, S ;

ENGELHARD, M ;

FISHER, RI ;

GISSELBRECHT, C ;

HORNING, SJ ;

LEPAGE, E ;

LISTER, TA ;

MEERWALDT, JH ;

MONTSERRAT, E ;

NISSEN, NI ;

OKEN, MM ;

PETERSON, BA ;

TONDINI, C ;

VELASQUEZ, WA ;

YEAP, BY .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :987-994

[9] Follicular lymphoma international prognostic index [J].

Solal-Céligny, P ;

Roy, P ;

Colombat, P ;

White, J ;

Armitage, JO ;

Arranz-Saez, R ;

Au, WY ;

Bellei, M ;

Brice, P ;

Caballero, D ;

Coiffier, B ;

Conde-Garcia, E ;

Doyen, C ;

Federico, M ;

Fisher, RI ;

Garcia-Conde, JF ;

Guglielmi, C ;

Hageenbeek, A ;

Haïoun, C ;

LeBlanc, M ;

Lister, AT ;

Lopez-Guillermo, A ;

McLaughlin, P ;

Milpied, N ;

Morel, P ;

Mounier, N ;

Proctor, SJ ;

Rohatiner, A ;

Smith, P ;

Soubeyran, P ;

Tilly, H ;

Vitolo, U ;

Zinzani, PL ;

Zucca, E ;

Montserrat, E .

BLOOD, 2004, 104 (05) :1258-1265

[10] Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group [J].

Van Cutsem, Eric ;

Moiseyenko, Vladimir M. ;

Tjulandin, Sergei ;

Majlis, Alejandro ;

Constenla, Manuel ;

Boni, Corrado ;

Rodrigues, Adriano ;

Fodor, Miguel ;

Chao, Yee ;

Voznyi, Edouard ;

Risse, Marie-Laure ;

Ajani, Jaffer A. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) :4991-4997

← 1 →